DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

NCT06645236 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer (mCRC)

Interventions

DEVICE: therascreen® KRAS RGQ PCR Kit

Sponsor

QIAGEN Gaithersburg, Inc